Article
Emergence of Erythromycin-Resistant Invasive Group A Streptococcus, West Virginia, USA, 2020-2021.
Emerging infectious diseases - 1 May 2023
Powell Lillie M, Choi Soo Jeon, Chipman Chloe E, Grund Megan E, LaSala P Rocco, Lukomski Slawomir
Abstract excerpt
Clindamycin and β-lactam antibiotics have been mainstays for treating invasive group A Streptococcus (iGAS) infection, yet such regimens might be limited for strains displaying MLSB phenotypes. We investigated 76 iGAS isolates from 66 patients in West Virginia, USA, during 2020-2021. We performed emm typing using Centers for Disease Control and Prevention guidelines and assessed resistance both genotypically and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
